Heart Test Laboratories Key Fundamental Indicators

HSCSW Stock  USD 0.11  0.0006  0.55%   
As of the 2nd of March, Heart Test retains the risk adjusted performance of 0.1202, and Market Risk Adjusted Performance of (1.76). Heart Test technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Heart Test Laboratories standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Heart Test is priced fairly, providing market reflects its last-minute price of 0.1094 per share. As Heart Test Laboratories appears to be a penny stock we also urge to confirm its total risk alpha numbers.

Heart Test Total Revenue

3,719.25

Heart Test's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Heart Test's valuation are provided below:
Gross Profit
K
Revenue
8.7 K
Earnings Share
(1.09)
Quarterly Revenue Growth
6.538
Revenue Per Share
0.006
There are over one hundred nineteen available fundamental trends for Heart Test Laboratories, which can be analyzed over time and compared to other ratios. All traders should should confirm Heart Test's regular fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Market Cap is likely to climb to about 4.9 M in 2026, whereas Enterprise Value is likely to drop slightly above 3.8 M in 2026. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
At this time, Heart Test's Depreciation And Amortization is fairly stable compared to the past year. Reconciled Depreciation is likely to climb to about 154.5 K in 2026, despite the fact that Net Interest Income is likely to grow to (427.9 K).
  
Build AI portfolio with Heart Stock

Heart Test Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.2 M4.9 M2.9 M
Slightly volatile
Short and Long Term Debt Total2.1 M2.7 M1.7 M
Slightly volatile
Other Current Liabilities691.3 K820.9 K490.1 K
Slightly volatile
Total Current Liabilities2.4 M4.3 M1.8 M
Slightly volatile
Property Plant And Equipment Net449.5 K500.5 K421.4 K
Pretty Stable
Current Deferred Revenue563.6 K767.2 K453.5 K
Slightly volatile
Accounts Payable511 K366.5 K405.5 K
Slightly volatile
CashM1.3 M1.1 M
Slightly volatile
Non Current Assets Total2.5 M2.4 M838.6 K
Slightly volatile
Long Term Debt546.2 K575 K739 K
Slightly volatile
Cash And Short Term InvestmentsM1.3 M1.1 M
Slightly volatile
Net Receivables4.8 KK154.1 K
Very volatile
Common Stock Shares Outstanding1.1 M1.1 M234.1 K
Slightly volatile
Liabilities And Stockholders Equity4.2 M4.9 M2.9 M
Slightly volatile
Non Current Liabilities Total268.9 K283.1 K877 K
Pretty Stable
Capital Lease Obligations388.3 K499.2 K331.3 K
Slightly volatile
Inventory565 K585.2 K770.7 K
Slightly volatile
Other Current Assets436.2 K481.6 K291.3 K
Slightly volatile
Other Stockholder Equity65.2 M87.8 M55 M
Slightly volatile
Total Liabilities4.2 M4.6 M2.7 M
Slightly volatile
Net Invested Capital2.5 M3.2 M1.7 M
Slightly volatile
Property Plant And Equipment Gross955.3 K1.1 M854.5 K
Slightly volatile
Short and Long Term Debt3.1 M2.9 M887.3 K
Slightly volatile
Total Current Assets3.2 M2.5 M2.2 M
Slightly volatile
Capital Stock1.3 K1.3 K3.6 K
Pretty Stable
Short Term Debt3.2 M3.1 M985.2 K
Slightly volatile
Common Stock1.6 KK2.6 K
Slightly volatile
Intangible Assets1.8 M1.9 M1.6 M
Slightly volatile

Heart Test Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization154.5 K147.1 K73.5 K
Slightly volatile
Interest Expense294.2 K575.5 K147 K
Slightly volatile
Selling General Administrative2.8 M4.6 M2.3 M
Slightly volatile
Total Revenue3.7 K3.9 K42.2 K
Slightly volatile
Other Operating Expenses5.9 M9.6 M4.8 M
Slightly volatile
Research DevelopmentMM2.5 M
Slightly volatile
Cost Of Revenue82.5 K149.3 K98.5 K
Pretty Stable
Total Operating Expenses5.8 M9.5 M4.7 M
Slightly volatile
Reconciled Depreciation154.5 K147.1 K73.5 K
Slightly volatile

Heart Test Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation207.4 K287.4 K167.2 K
Slightly volatile
Begin Period Cash FlowM6.7 M2.9 M
Slightly volatile
Depreciation154.5 K147.1 K73.5 K
Slightly volatile
Capital Expenditures34.4 K34.7 K21.2 K
Slightly volatile
Issuance Of Capital Stock1.3 M1.3 M2.2 M
Slightly volatile
Total Cash From Financing Activities5.1 M3.1 M3.1 M
Slightly volatile
End Period Cash FlowM1.3 M1.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio392681282
Slightly volatile
Days Sales Outstanding47.1553.0557.9013
Slightly volatile
Average Payables277.8 K312.6 K341.2 K
Slightly volatile
Stock Based Compensation To Revenue54.2951.715.3054
Slightly volatile
Capex To Depreciation0.340.210.2745
Slightly volatile
Inventory Turnover0.190.180.1277
Pretty Stable
Days Of Inventory On HandK2.1 K3.4 K
Pretty Stable
Payables Turnover0.390.370.2762
Pretty Stable
Average Inventory570 K641.2 K699.9 K
Slightly volatile
Research And Ddevelopement To Revenue953907241
Slightly volatile
Capex To Revenue6.566.251.8813
Slightly volatile
Cash Per Share1.281.3514.1526
Slightly volatile
Days Payables Outstanding979KK
Pretty Stable
Income Quality1.00.970.9691
Slightly volatile
Intangibles To Total Assets0.220.340.1932
Slightly volatile
Current Ratio0.50.531.3401
Very volatile
Receivables Turnover4.955.576.0829
Slightly volatile
Capex Per Share0.03520.0370.2481
Slightly volatile
Average Receivables928K1.1 K
Slightly volatile
Revenue Per Share0.00510.00531.218
Slightly volatile
Interest Debt Per Share4.064.2736.3448
Very volatile
Debt To Assets1.160.810.7429
Slightly volatile
Operating Cycle2.4 K2.5 K3.5 K
Pretty Stable
Days Of Payables Outstanding979KK
Pretty Stable
Ebt Per Ebit0.820.940.9916
Pretty Stable
Total Debt To Capitalization1.021.084.2215
Pretty Stable
Quick Ratio0.350.370.7761
Pretty Stable
Cash Ratio0.250.270.6061
Pretty Stable
Days Of Inventory OutstandingK2.1 K3.4 K
Pretty Stable
Days Of Sales Outstanding47.1553.0557.9013
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.90.9864
Slightly volatile
Fixed Asset Turnover0.01090.01150.1052
Slightly volatile
Debt Ratio1.160.810.7429
Slightly volatile
Price Sales Ratio392681282
Slightly volatile
Asset Turnover0.00110.00120.0209
Slightly volatile

Heart Test Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.9 M3.8 MM
Slightly volatile

Heart Fundamental Market Drivers

Heart Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Heart Test is extremely important. It helps to project a fair market value of Heart Stock properly, considering its historical fundamentals such as Operating Margin. Since Heart Test's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heart Test's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heart Test's interrelated accounts and indicators.

Search Suggestions

HSC HSCCryptocurrency
HSCC Homeland Security CpCompany
HSCSX Small Company Stock FundMutual Fund
HSCZ iShares Currency HedgedETF
HSC EnviriCompanyDelisted
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Heart Pretax Profit Margin

Pretax Profit Margin

(2,201.38)

At this time, Heart Test's Pretax Profit Margin is fairly stable compared to the past year.
Based on the recorded statements, Heart Test Laboratories has an Operating Margin of -857.1323%. This is much higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.

Heart Test Laboratories Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Heart Test's current stock value. Our valuation model uses many indicators to compare Heart Test value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heart Test competition to find correlations between indicators driving Heart Test's intrinsic value. More Info.
Heart Test Laboratories is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Heart Test's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Heart Test by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Heart Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heart Test's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics of similar companies.
Heart Test is currently under evaluation in operating margin category among its peers.

Heart Fundamentals

About Heart Test Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heart Test Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heart Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heart Test Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue767.2 K563.6 K
Total Revenue3.9 K3.7 K
Cost Of Revenue149.3 K82.5 K
Stock Based Compensation To Revenue 51.70  54.29 
Research And Ddevelopement To Revenue 907.47  952.84 
Capex To Revenue 6.25  6.56 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue-2.2 K-2.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.